Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • yougottasayyes yougottasayyes Dec 5, 2012 12:22 AM Flag

    My Gilead question was deleted too....who deletes these posts?

    You are correct that the 100% SVR was not achieved, but this is not surprising in larger studies. I would be surprised if the 78% drops by more than 1 or 2% (if at all) since the SVR12 timepoint is VERY predictive of SVR24 (lots of data that shows this) and without Peg on-board, it is is likely that anyone who would have relapsed would have done so before the 12 week follow-up visit (Peg has a longer half-life than the orals). I would say the result is only disappointing if you are a perfectionist. It is still a very admirable result and great for the patients. I have no monetary interests. Good luck to everyone!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • understood. My beef is with how the company portrayed the medicine and how wall st jumped to 100% cure rate so quickly. In reality it will probably be somewhere in the 70s. So slightly worse the Incivek but without the rash. Good med but not as good as has been portrayed to date. Of course as happened with Incivek, if another Nuc a year or two behind GILD's has a better cure rate/oral/no rash then the doctors/patients will do exactly what they did with Incivek and start warehousing patients all over again.

 
VRTX
82.00-4.61(-5.32%)Feb 8 4:00 PMEST